Company Overview of Kamedis Ltd.
Kamedis Ltd. operates as a dermo-cosmetics company that develops topical skincare products for adults, children, and infants. Its portfolio includes a line of dry skin products, such as face and body washes, and foot gels formulated to assist in relieving irritated and itchy skin symptoms caused by dry skin; a line of oily skin products, which include facial cleansers, face creams, and spot treatment creams formulated to assist in relieving facial skin symptoms related to oily prone skin; a line of scaly skin products comprising body creams, shampoos, scalp care lotions, T-Zone cleansers, and T-Zone creams formulated to assist in relieving scalp and body skin that is scaly and irritated due ...
P.O.B 5819121 Dvora Hanevia' st
Tel Aviv, 6944038
Founded in 1998
Key Executives for Kamedis Ltd.
Vice President of Operations
Chief Technology Officer and Head of R&D
Executive Vice President of U.S. Operations
Compensation as of Fiscal Year 2017.
Kamedis Ltd. Key Developments
Perrigo Seeks Buyer For Ramat Hovav Plant
Mar 1 17
Perrigo Company plc (NYSE:PRGO) might prefer to sell Ramat Hovav plant. Perrigo Company announced that it was looking for strategic alternatives to Israel for the production of its active ingredients. Perrigo Company announced that as part of its cutbacks, it was looking for strategic alternatives to Israel for the production of its active ingredients. In response to a question on February 28, 2017, from Globes, Perrigo said that it preferred to sell its Ramat Hovav plant as a single unit, including the employees, to shutting it down. Perrigo Company said, "The plant is currently profitable, and closing it down is not urgent. It is very likely that a buyer will be found, and the plant will continue to operate and prosper." In its conference call, Perrigo mentioned the possibility of selling only its business in Ramat Hovav. Perrigo Company prefers to find a buyer for the plant. Another possibility is the acquisition of the company's plant by a biomed company in the advanced stages of entering the market with its products. Companies that might take an interest such a plant include Foamix Pharmaceuticals Ltd. (NasdaqGM:FOMX), Kitov Pharmaceuticals Holdings LTD (TASE:KTOV), Kamedis Ltd., Intec Pharma Ltd. (TASE:NTEC), PolyPid Ltd., MediWound Ltd. (NasdaqGM:MDWD), RedHill Biopharma Ltd. (TASE:RDHL) and others.
Kamedis Inc. and Taro Pharmaceutical Industries Ltd Announce Availability of the Kamedis® Bio-Herbal Dandruff Care System At Walgreens
Feb 10 16
Kamedis Inc. announced the launch and retail availability of the Kamedis® Bio-Herbal Dandruff Care system in collaboration with Taro Pharmaceutical Industries Ltd. Dandruff is the most common scalp disorder in adolescence and adulthood, effecting more than 50 million people in United States. Both products in the Kamedis Bio-Herbal Dandruff Care system a scalp lotion and dandruff shampoo are infused with Botaniplex, a groundbreaking combination of botanical concentrates and clinically proven active ingredients to visibly reduce scaling and treat the itching at the source, all while nourishing and hydrating the scalp. Botaniplex utilizes a proprietary process to purify and concentrate the botanical extracts for maximum efficacy. The system fights dandruff in two ways. The active ingredient, pyrithione zinc, kills the fungus that is the culprit behind many cases of dandruff and seborrheic dermatitis, and the botanical concentrates soothe, hydrate and nourish the hair and scalp, relieving the common symptoms of dandruff. The formulation is also free of parabens, steroids and sodium lauryl sulfates (SLS), making Kamedis both gentle on the scalp and safe to use on color-treated hair.
Kamedis Bio Herbal Skincare Presents at BIO-Europe 2015, Nov-02-2015
Oct 1 15
Kamedis Bio Herbal Skincare Presents at BIO-Europe 2015, Nov-02-2015 . Venue: Munich, Germany.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|